Sjogren syndrome: Advances in the pathogenesis from animal models

被引:76
作者
Chiorini, J. A. [1 ]
Cihakova, D. [2 ]
Ouellette, C. E. [3 ]
Caturegli, P. [2 ,3 ]
机构
[1] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, DHHS, Bethesda, MD USA
[2] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA
关键词
Sjogren syndrome; Mouse models; Autoimmunity; LYMPHOID-TISSUE LYMPHOMA; SYNDROME-LIKE DISEASE; SALIVARY-GLAND; CLASSIFICATION CRITERIA; AUTOIMMUNE-DISEASES; PULMONARY INVOLVEMENT; CARBONIC-ANHYDRASE; LUNG INVOLVEMENT; INTERFERON-GAMMA; AIRWAY DISEASE;
D O I
10.1016/j.jaut.2009.09.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sjogren syndrome is an autoimmune disease characterized by hyposecretion of the lacrimal and salivary glands, resulting in dryness of the eyes and mouth. Individuals may experience primary Sjogren syndrome or a secondary form accompanying another rheumatic autoimmune disease, such as rheumatoid arthritis or systemic lupus erythematosus. The pathogenic mechanisms of Sjogren syndrome remain largely unknown, in part a consequence of the heterogeneity of the disease. Animal models have shed light on the connections between specific pathways and symptoms, but an ideal system is wanting. Improved disease models will enable a better understanding of Sjogren syndrome, including how immune tolerance is lost and potential therapeutic interventions. Most importantly, an optimal model will enable detection of disease biomarkers, since injury to the salivary glands may precede lymphocytic infiltration. This review aims to characterize available mice models of Sjogren syndrome, including advantages and disadvantages, from the researcher's perspective. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 80 条
[1]   Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection [J].
Ambrosetti, A ;
Zanotti, R ;
Pattaro, C ;
Lenzi, L ;
Chilosi, M ;
Caramaschi, P ;
Arcaini, L ;
Pasini, F ;
Biasi, D ;
Orlandi, E ;
D'Adda, M ;
Lucioni, M ;
Pizzolo, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (01) :43-49
[2]  
ANDERSON LG, 1972, CLIN EXP IMMUNOL, V10, P199
[3]  
Battista Giuseppe, 2003, Radiol Med, V106, P445
[4]   Autoimmunity: From the mosaic to the kaleidoscope [J].
Blank, Miri ;
Gershwin, M. Eric .
JOURNAL OF AUTOIMMUNITY, 2008, 30 (1-2) :1-4
[5]  
Brayer J, 2000, J RHEUMATOL, V27, P1896
[6]   Autoimmune thyroiditis and ROS [J].
Burek, C. Lynne ;
Rose, Noel R. .
AUTOIMMUNITY REVIEWS, 2008, 7 (07) :530-537
[7]   Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside [J].
Buyon, Jill P. ;
Clancy, Robert M. ;
Friedman, Deborah M. .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2009, 5 (03) :139-148
[8]   ANTIBODIES TO CARBONIC ANHYDRASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES: RELATIONSHIP WITH LUNG INVOLVEMENT [J].
Caccavo, D. ;
Afeltra, A. ;
Rigon, A. ;
Vadacca, M. ;
Zobel, B. B. ;
Zennaro, D. ;
Arcarese, L. ;
Buzzulini, F. ;
Pellegrino, N. M. ;
Amoroso, A. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2008, 21 (03) :659-667
[9]   Autoimmune thyroid diseases [J].
Caturegli, Patrizio ;
Kimura, Hiroaki ;
Rocchi, Roberto ;
Rose, Noel R. .
CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (01) :44-48
[10]   Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background [J].
Cha, S ;
Nagashima, H ;
Brown, VB ;
Peck, AB ;
Humphreys-Beher, MG .
ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1390-1398